News 18th April 2022 Albion News - Spring 2022 edition Welcome to the latest edition of our newsletter, which is available to view online or as a downloadable pdf. Read more
Investment 11th April 2022 Albion invests in RegGenome We are pleased to announce our investment in Regulatory Genome Development Ltd (RegGenome), a commercial spin-out from the University of Cambridge. Read more
Exit 4th April 2022 MyMeds&Me announces exit to a private equity company MyMeds&Me; a digital pharma company, has been acquired by Drug Safety and Pharmacovigilance Services Solutions (DSS) Read more
Investment 31st March 2022 AlbionVC leads a £13m Series A extension in TransFICC Albion announces that is had led a £17 million Series A extension in TransFICC alongside existing institutional shareholders, which follows the original Series A for £7.8 million, announced in April 2020.TransFICC’s investors are AlbionV... Read more
Insights 14th March 2022 How economic events weigh on early stage investing Sadly the Ukraine humanitarian crisis, further acceleration of inflation and an economic slowdown in Europe are certainties. How does this backdrop impact early stage investing? Read more
Insights 14th March 2022 How economic events weigh on early stage investing Sadly the Ukraine humanitarian crisis, further acceleration of inflation and an economic slowdown in Europe are certainties. How does this backdrop impact early stage investing? Read more
Insights 8th March 2022 This International Women’s Day, we celebrate all the brilliant women at Albion. We’ve asked a few volunteers to share insights about their careers, role models, lessons learnt, lack of funding to female founders and more. Read more
News 24th February 2022 Academia raises £16m Series D to accelerate the world’s research Academia, a platform for sharing academic research, has raised £16 million in Series D funding from Tencent and other investors. Read more
